DIAGENICS

Diagenics Group SE is a biopharmaceutical company and is a pioneer in innovative diagnostics for the early detection of important diseases such as heart attack (ACS), stroke and preeclampsia. This early detection is based on a new and innovative biomarker that was developed by Diagenics Group SE. Diagnostic results are faster and more accurate, which in turn is inexpensive and reduces the frequency of misdiagnosis.

Also known as: Diagenics Group SE

Primary location: Bissen Luxembourg